Where are the biggest points of friction between drug development and commercial manufacturing today, and how can the industry remove them? FUJIFILM Biotechnologies, Systech and Pace Life Sciences discuss.
Christiane Bardroff, chief business officer, FUJIFILM Biotechnologies
1. Where do you see the biggest points of friction as a drug moves from development into commercial